Cargando…
Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study
Cancer chemotherapy-induced cognitive impairment (chemobrain) is a major complication that affects the prognosis of therapy. Our study evaluates the nootropic-like activity of levetiracetam (LEVE) against doxorubicin (DOX)-induced memory defects using in vivo and molecular modelling. Rats were treat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653834/ https://www.ncbi.nlm.nih.gov/pubmed/36364190 http://dx.doi.org/10.3390/molecules27217364 |
_version_ | 1784828779052400640 |
---|---|
author | Mani, Vasudevan Arfeen, Minhajul Rabbani, Syed Imam Shariq, Ali Amirthalingam, Palanisamy |
author_facet | Mani, Vasudevan Arfeen, Minhajul Rabbani, Syed Imam Shariq, Ali Amirthalingam, Palanisamy |
author_sort | Mani, Vasudevan |
collection | PubMed |
description | Cancer chemotherapy-induced cognitive impairment (chemobrain) is a major complication that affects the prognosis of therapy. Our study evaluates the nootropic-like activity of levetiracetam (LEVE) against doxorubicin (DOX)-induced memory defects using in vivo and molecular modelling. Rats were treated with LEVE (100 and 200 mg/kg, 30 days) and chemobrain was induced by four doses of DOX (2 mg/kg, i.p.). Spatial memory parameters were evaluated using an elevated plus maze (EPM) and Y-maze. Additionally, acetylcholinesterase (AChE) and the neuroinflammatory biomarkers cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), nuclear factor-κB (NF-κB), and tumor necrosis factor-alpha (TNF-α) were analyzed using brain homogenate. PharmMapper was used for inverse docking and AutoDock Vina was used for molecular docking. LEVE treatment significantly diminished the DOX-induced memory impairment parameters in both the EPM and Y-maze. In addition, the drug treatment significantly reduced AChE, COX-2, PGE2, NF-κB, and TNF-α levels compared to DOX-treated animals. The inverse docking procedures resulted in the identification of AChE as the potential target. Further molecular modelling studies displayed interactions with residues Gly118, Gly119, and Ser200, critical for the hydrolysis of ACh. Analysis of the results suggested that administration of LEVE improved memory-related parameters in DOX-induced animals. The ‘nootropic-like’ activity could be related to diminished AChE and neuroinflammatory mediator levels. |
format | Online Article Text |
id | pubmed-9653834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96538342022-11-15 Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study Mani, Vasudevan Arfeen, Minhajul Rabbani, Syed Imam Shariq, Ali Amirthalingam, Palanisamy Molecules Article Cancer chemotherapy-induced cognitive impairment (chemobrain) is a major complication that affects the prognosis of therapy. Our study evaluates the nootropic-like activity of levetiracetam (LEVE) against doxorubicin (DOX)-induced memory defects using in vivo and molecular modelling. Rats were treated with LEVE (100 and 200 mg/kg, 30 days) and chemobrain was induced by four doses of DOX (2 mg/kg, i.p.). Spatial memory parameters were evaluated using an elevated plus maze (EPM) and Y-maze. Additionally, acetylcholinesterase (AChE) and the neuroinflammatory biomarkers cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), nuclear factor-κB (NF-κB), and tumor necrosis factor-alpha (TNF-α) were analyzed using brain homogenate. PharmMapper was used for inverse docking and AutoDock Vina was used for molecular docking. LEVE treatment significantly diminished the DOX-induced memory impairment parameters in both the EPM and Y-maze. In addition, the drug treatment significantly reduced AChE, COX-2, PGE2, NF-κB, and TNF-α levels compared to DOX-treated animals. The inverse docking procedures resulted in the identification of AChE as the potential target. Further molecular modelling studies displayed interactions with residues Gly118, Gly119, and Ser200, critical for the hydrolysis of ACh. Analysis of the results suggested that administration of LEVE improved memory-related parameters in DOX-induced animals. The ‘nootropic-like’ activity could be related to diminished AChE and neuroinflammatory mediator levels. MDPI 2022-10-29 /pmc/articles/PMC9653834/ /pubmed/36364190 http://dx.doi.org/10.3390/molecules27217364 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mani, Vasudevan Arfeen, Minhajul Rabbani, Syed Imam Shariq, Ali Amirthalingam, Palanisamy Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study |
title | Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study |
title_full | Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study |
title_fullStr | Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study |
title_full_unstemmed | Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study |
title_short | Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study |
title_sort | levetiracetam ameliorates doxorubicin-induced chemobrain by enhancing cholinergic transmission and reducing neuroinflammation using an experimental rat model and molecular docking study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653834/ https://www.ncbi.nlm.nih.gov/pubmed/36364190 http://dx.doi.org/10.3390/molecules27217364 |
work_keys_str_mv | AT manivasudevan levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy AT arfeenminhajul levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy AT rabbanisyedimam levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy AT shariqali levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy AT amirthalingampalanisamy levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy |